ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 132 filers reported holding ANAPTYSBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169,237 | +6.4% | 9,423 | +20.5% | 0.00% | – |
| Q2 2023 | $159,038 | -49.5% | 7,819 | -46.0% | 0.00% | – |
| Q1 2023 | $315,150 | -72.0% | 14,483 | -60.1% | 0.00% | -100.0% |
| Q4 2022 | $1,124,968 | +29.3% | 36,301 | +6.5% | 0.00% | 0.0% |
| Q3 2022 | $870,000 | +25.4% | 34,080 | -0.2% | 0.00% | – |
| Q2 2022 | $694,000 | +168.0% | 34,151 | +226.1% | 0.00% | – |
| Q1 2022 | $259,000 | -36.4% | 10,474 | -10.6% | 0.00% | – |
| Q4 2021 | $407,000 | +35.2% | 11,712 | +5.6% | 0.00% | – |
| Q3 2021 | $301,000 | +1.3% | 11,094 | -3.1% | 0.00% | – |
| Q2 2021 | $297,000 | +0.3% | 11,448 | -16.5% | 0.00% | – |
| Q1 2021 | $296,000 | -18.2% | 13,713 | -18.6% | 0.00% | – |
| Q4 2020 | $362,000 | +119.4% | 16,847 | +50.5% | 0.00% | – |
| Q3 2020 | $165,000 | -27.3% | 11,195 | +10.2% | 0.00% | – |
| Q2 2020 | $227,000 | -89.0% | 10,155 | -93.0% | 0.00% | -100.0% |
| Q1 2020 | $2,056,000 | -30.9% | 145,516 | -20.6% | 0.00% | 0.0% |
| Q4 2019 | $2,975,000 | +955.0% | 183,172 | +2158.3% | 0.00% | – |
| Q3 2019 | $282,000 | -81.1% | 8,111 | -69.4% | 0.00% | -100.0% |
| Q2 2019 | $1,494,000 | +20.9% | 26,507 | +56.5% | 0.00% | 0.0% |
| Q1 2019 | $1,236,000 | -74.1% | 16,934 | -77.4% | 0.00% | -66.7% |
| Q4 2018 | $4,774,000 | -63.4% | 74,864 | -42.7% | 0.00% | -25.0% |
| Q3 2018 | $13,045,000 | -35.6% | 130,759 | -54.2% | 0.00% | -33.3% |
| Q2 2018 | $20,261,000 | +1.5% | 285,223 | +48.8% | 0.01% | -40.0% |
| Q1 2018 | $19,952,000 | +3.0% | 191,716 | -0.3% | 0.01% | -16.7% |
| Q4 2017 | $19,373,000 | +429.2% | 192,361 | +83.6% | 0.01% | +300.0% |
| Q3 2017 | $3,661,000 | +234.9% | 104,795 | +128.8% | 0.00% | +200.0% |
| Q2 2017 | $1,093,000 | +2702.6% | 45,806 | +3054.7% | 0.00% | – |
| Q1 2017 | $39,000 | – | 1,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |